These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22471308)

  • 1. Nanomedicine for intracellular therapy.
    Ranjan A; Pothayee N; Seleem MN; Boyle SM; Kasimanickam R; Riffle JS; Sriranganathan N
    FEMS Microbiol Lett; 2012 Jul; 332(1):1-9. PubMed ID: 22471308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin-modified nanoparticles for efficient targeting and preconcentration of Gram-positive and Gram-negative bacteria.
    Kell AJ; Stewart G; Ryan S; Peytavi R; Boissinot M; Huletsky A; Bergeron MG; Simard B
    ACS Nano; 2008 Sep; 2(9):1777-88. PubMed ID: 19206416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucoidan coated ciprofloxacin loaded chitosan nanoparticles for the treatment of intracellular and biofilm infections of Salmonella.
    S E; T R N; V K R; Baranwal G; Biswas R; R J; S S
    Colloids Surf B Biointerfaces; 2017 Dec; 160():40-47. PubMed ID: 28922635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches for drug delivery systems in nanomedicine: effects of particle design and shape.
    Daum N; Tscheka C; Neumeyer A; Schneider M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(1):52-65. PubMed ID: 22140017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of enteric Salmonella infections.
    Grassl GA; Finlay BB
    Curr Opin Gastroenterol; 2008 Jan; 24(1):22-6. PubMed ID: 18043228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of chloramphenicol loaded chondroitin sulfate and dextran sulfate nanoparticles to treat intracellular Salmonella infections.
    Kiruthika V; Maya S; Suresh MK; Kumar VA; Jayakumar R; Biswas R
    Colloids Surf B Biointerfaces; 2015 Mar; 127():33-40. PubMed ID: 25645750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery systems to increase the selectivity of antibiotics in phagocytic cells.
    Briones E; Colino CI; Lanao JM
    J Control Release; 2008 Feb; 125(3):210-27. PubMed ID: 18077047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle formulations in pulmonary drug delivery.
    Bailey MM; Berkland CJ
    Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human health consequences of antimicrobial drug-resistant Salmonella and other foodborne pathogens.
    Mølbak K
    Clin Infect Dis; 2005 Dec; 41(11):1613-20. PubMed ID: 16267734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct attachment of nanoparticle cargo to Salmonella typhimurium membranes designed for combination bacteriotherapy against tumors.
    Kazmierczak R; Choe E; Sinclair J; Eisenstark A
    Methods Mol Biol; 2015; 1225():151-63. PubMed ID: 25253255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging trends of nanomedicine--an overview.
    Sandhiya S; Dkhar SA; Surendiran A
    Fundam Clin Pharmacol; 2009 Jun; 23(3):263-9. PubMed ID: 19527298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial nanomedicine.
    Yacoby I; Benhar I
    Nanomedicine (Lond); 2008 Jun; 3(3):329-41. PubMed ID: 18510428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasion and intracellular proliferation of Salmonella within non-phagocytic cells.
    García-del Portillo F; Finlay BB
    Microbiologia; 1994 Sep; 10(3):229-38. PubMed ID: 7873099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles for intracellular-targeted drug delivery.
    Paulo CS; Pires das Neves R; Ferreira LS
    Nanotechnology; 2011 Dec; 22(49):494002. PubMed ID: 22101232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmonella sensing of anti-microbial mechanisms to promote survival within macrophages.
    Prost LR; Sanowar S; Miller SI
    Immunol Rev; 2007 Oct; 219():55-65. PubMed ID: 17850481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.